Skip to content

Cognex

US · CGNX #1393 by market cap Listed 1970
44.36 -3.30 -6.92%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Fair Value how this is computed

Near fair value
25.82 fair value ≈ 37.54 49.26
  • Implied fair-value range of 25.82-49.26, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +18.2% above the average-multiple fair value of 37.54.

Valuation each multiple against its own 5-year range

P/B ratio 4.89 In line with history 38th percentile
5-year average 5.53 · #28 of 32 in Scientific & Technical Instruments
P/E ratio 34.97 Cheap vs history 10th percentile
5-year average 55.21 · forward 26.03 · #11 of 18 in Scientific & Technical Instruments
P/S ratio 7.48 Cheap vs history 29th percentile
5-year average 8.45 · forward 6.83 · #24 of 32 in Scientific & Technical Instruments

Vs. peers Scientific & Technical Instruments

Company Market cap P/E (TTM) P/B Div yield
Cognex (CGNX) 7.47B 31.02 4.34 0.77%
Garmin (GRMN) 51.65B 25.75 5.41 1.46%
Keysight Technologies (KEYS) 44.43B 29.89 6.39 0.00%
Coherent (COHR) 36.87B 38.76 3.25 0.00%
Teledyne Technologies (TDY) 27.56B 27.41 2.47 0.00%
Fortive (FTV) 19.10B 30.85 3.21 0.39%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★☆ Fair value54.43 Economic moatNarrow UncertaintyMedium

Trading 22.7% below Morningstar's fair value estimate.

Fair value

Cognex Corp is assigned a 4-star quantitative star rating, reflecting our opinion that this share class offers a somewhat attractive opportunity for investors. The stock currently trades at a 8% discount to our quantitative fair value estimate of $54.43 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.

The company's balance sheet increases our estimated valuation. Low leverage mitigates financial risk, potentially boosting a firm's value. Reflecting the firm's leverage is its debt to EBITDA ratio of 0.2, which sits in the bottom 10% compared with global peers. Without much debt relative to assets, this company should exhibit high resilience should the global economy weaken; if not, the company could raise debt and invest in the business or return capital to shareholders. We believe this is a sign that shares could be undervalued.

On a different note, the company's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 21.4%, for example, lies in the bottom 20% globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which, despite our favorable price/fair value ratio, is a negative attribute.

Economic moat

The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-11-20 20:02:15 · For reference only, not investment advice and not tailored to your situation.

Cognex discussion 0 comments

Add a comment